| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Pharmacy (Drs. Sullivan and Lee), Medicine (Dr. Ramsey), and Health Services (Drs. Sullivan and Ramsey), University of Washington, Seattle, WA.
Correspondence to: Sean D. Sullivan, PhD, Department of Pharmacy, Box 357630, University of Washington, Seattle, WA 98195; e-mail: sdsull{at}u.washington.edu
COPD is one of the leading causes of morbidity and mortality worldwide and imparts a substantial economic burden on individuals and society. Despite the intense interest in COPD among clinicians and researchers, there is a paucity of data on health-care utilization, costs, and social burden in this population. The total economic costs of COPD morbidity and mortality in the United States were estimated at $23.9 billion in 1993. Direct treatments for COPD-related illness accounted for $14.7 billion, and the remaining $9.2 billion were indirect morbidity and premature mortality estimated as lost future earnings. Similar data from another US study suggest that 10% of persons with COPD account for > 70% of all medical care costs. International studies of trends in COPD-related hospitalization indicate that although the average length of stay has decreased since 1972, admissions per 1,000 persons per year for COPD have increased in all age groups > 45 years of age. These trends reflect population aging, smoking patterns, institutional factors, and treatment practices.
Key Words: COPD • pharmacoeconomics
This article has been cited by other articles:
|
|
 |
|
  B. S. Quon, W. Q. Gan, and D. D. Sin Contemporary Management of Acute Exacerbations of COPD: A Systematic Review and Metaanalysis Chest, March 1, 2008; 133(3): 756 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A. S. Buist, and D. M. Mannino Global burden of COPD: systematic review and meta-analysis Eur. Respir. J., September 1, 2006; 28(3): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. G. Halpin Health Economics of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2006; 3(3): 227 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-C. Ong, A. Earnest, and S.-J. Lu A Multidimensional Grading System (BODE Index) as Predictor of Hospitalization for COPD Chest, December 1, 2005; 128(6): 3810 - 3816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Hurst, G. C. Donaldson, T. M. A. Wilkinson, W. R. Perera, and J. A. Wedzicha Epidemiological relationships between the common cold and exacerbation frequency in COPD Eur. Respir. J., November 1, 2005; 26(5): 846 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Turino Therapeutic Gains of Prolonged Bronchial Dilatation in Chronic Obstructive Pulmonary Disease Ann Intern Med, September 6, 2005; 143(5): 386 - 387. [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Sullivan, P. L. Simonian, M. T. Falta, J. D. Mitchell, G. P. Cosgrove, K. K. Brown, B. L. Kotzin, N. F. Voelkel, and A. P. Fontenot Oligoclonal CD4+ T Cells in the Lungs of Patients with Severe Emphysema Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 590 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Statement on Home Care for Patients with Respiratory Disorders Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1443 - 1464. [Full Text] [PDF]
|
|
|
|
 |
|
 M A Puhan, H J Schunemann, M Frey, M Scharplatz, and L M Bachmann How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction Thorax, May 1, 2005; 60(5): 367 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sin and S. F. P. Man Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality Proceedings of the ATS, April 1, 2005; 2(1): 8 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Hurst and J A Wedzicha Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation Postgrad. Med. J., September 1, 2004; 80(947): 497 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Snyder and M. D. Eisner Obstructive Lung Disease Among the Urban Homeless Chest, May 1, 2004; 125(5): 1719 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Monninkhofe, P Van der valk, T Schermer, J Van der palen, C Van herwaarden, and G Zielhuis Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease Chronic Respiratory Disease, January 1, 2004; 1(1): 7 - 16. [Abstract] [PDF]
|
|
|
|
 |
|
 D. D. Sin, F. A. McAlister, S. F. P. Man, and N. R. Anthonisen Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review JAMA, November 5, 2003; 290(17): 2301 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Highland, C. Strange, and J. E. Heffner Long-Term Effects of Inhaled Corticosteroids on FEV1 in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis Ann Intern Med, June 17, 2003; 138(12): 969 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.D. Ramsey and S.D. Sullivan The burden of illness and economic evaluation for COPD Eur. Respir. J., June 1, 2003; 21(41_suppl): 29S - 35s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-A. Jansson, F. Andersson, S. Borg, A. Ericsson, E. Jonsson, and B. Lundback Costs of COPD in Sweden According to Disease Severity Chest, December 1, 2002; 122(6): 1994 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rennard, M. Decramer, P.M.A. Calverley, N.B. Pride, J.B. Soriano, P.A. Vermeire, and J. Vestbo Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Eur. Respir. J., October 1, 2002; 20(4): 799 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Mannino COPD* : Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity Chest, May 1, 2002; 121(5_suppl): 121S - 126S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yelin, L. Trupin, M. Cisternas, M. Eisner, P. Katz, and P. Blanc A national study of medical care expenditures for respiratory conditions Eur. Respir. J., March 1, 2002; 19(3): 414 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Casaburi, D.A. Mahler, P.W. Jones, A. Wanner, G. San Pedro, R.L. ZuWallack, S.S. Menjoge, C.W. Serby, and T. Witek Jr A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2002; 19(2): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
